199 related articles for article (PubMed ID: 29923556)
1. Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis.
Yu RY; Xing L; Cui PF; Qiao JB; He YJ; Chang X; Zhou TJ; Jin QR; Jiang HL; Xiao Y
Biomater Sci; 2018 Jul; 6(8):2144-2155. PubMed ID: 29923556
[TBL] [Abstract][Full Text] [Related]
2. Stable and sustained release liposomal formulations of celecoxib: In vitro and in vivo anti-tumor evaluation.
Matbou Riahi M; Sahebkar A; Sadri K; Nikoofal-Sahlabadi S; Jaafari MR
Int J Pharm; 2018 Apr; 540(1-2):89-97. PubMed ID: 29371019
[TBL] [Abstract][Full Text] [Related]
3. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
[TBL] [Abstract][Full Text] [Related]
4. Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
Luchsinger C; Aguilar M; Burgos PV; Ehrenfeld P; Mardones GA
PLoS One; 2018; 13(4):e0195401. PubMed ID: 29614107
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells.
Limasale YD; Tezcaner A; Özen C; Keskin D; Banerjee S
Int J Pharm; 2015 Feb; 479(2):364-73. PubMed ID: 25595386
[TBL] [Abstract][Full Text] [Related]
6. Regulation of vesicle transport and cell motility by Golgi-localized Dbs.
Fitzpatrick ER; Hu T; Ciccarelli BT; Whitehead IP
Small GTPases; 2014; 5(4):1-12. PubMed ID: 25483302
[TBL] [Abstract][Full Text] [Related]
7. Processing to endoglycosidase H-resistant thyrotropin subunits occurs in the presence of brefeldin-A: evidence favoring the recycling of Golgi membranes to the rough endoplasmic reticulum in mouse thyrotrophs.
Johnson MJ; Miura Y; Rubin D; Magner JA
Thyroid; 1991; 1(2):185-94. PubMed ID: 1822366
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
11. A Golgi-related structure remains after the brefeldin A-induced formation of an ER-Golgi hybrid compartment.
De Lemos-Chiarandini C; Ivessa NE; Black VH; Tsao YS; Gumper I; Kreibich G
Eur J Cell Biol; 1992 Aug; 58(2):187-201. PubMed ID: 1425761
[TBL] [Abstract][Full Text] [Related]
12. Comparative Evaluation of Nimesulide-Loaded Nanoparticles for Anticancer Activity Against Breast Cancer Cells.
Sengel-Turk CT; Hascicek C; Bakar F; Simsek E
AAPS PharmSciTech; 2017 Feb; 18(2):393-403. PubMed ID: 27007742
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.
Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y
J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer.
Alqahtani AM; Chidambaram K; Pino-Figueroa A; Chandrasekaran B; Dhanaraj P; Venkatesan K
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1916-1927. PubMed ID: 33660801
[TBL] [Abstract][Full Text] [Related]
15. Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles.
Zhong T; He B; Cao HQ; Tan T; Hu HY; Li YP; Zhang ZW
Acta Pharmacol Sin; 2017 Jun; 38(6):924-930. PubMed ID: 28504249
[TBL] [Abstract][Full Text] [Related]
16. BFA-induced compartments from the Golgi apparatus and trans-Golgi network/early endosome are distinct in plant cells.
Lam SK; Cai Y; Tse YC; Wang J; Law AH; Pimpl P; Chan HY; Xia J; Jiang L
Plant J; 2009 Dec; 60(5):865-81. PubMed ID: 19709389
[TBL] [Abstract][Full Text] [Related]
17. Effects of Brefeldin A on the Golgi complex, endoplasmic reticulum and viral envelope glycoproteins in murine erythroleukemia cells.
Ulmer JB; Palade GE
Eur J Cell Biol; 1991 Feb; 54(1):38-54. PubMed ID: 2032551
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary surfactant phosphatidylcholine transport bypasses the brefeldin A sensitive compartment of alveolar type II cells.
Osanai K; Mason RJ; Voelker DR
Biochim Biophys Acta; 2001 Apr; 1531(3):222-9. PubMed ID: 11325613
[TBL] [Abstract][Full Text] [Related]
19. Cell survival and protein secretion associated with Golgi integrity in response to Golgi stress-inducing agents.
Ignashkova TI; Gendarme M; Peschk K; Eggenweiler HM; Lindemann RK; Reiling JH
Traffic; 2017 Aug; 18(8):530-544. PubMed ID: 28485883
[TBL] [Abstract][Full Text] [Related]
20. Sulfation in the Golgi lumen of Madin-Darby canine kidney cells is inhibited by brefeldin A and depends on a factor present in the cytoplasm and on Golgi membranes.
Fjeldstad K; Pedersen ME; Vuong TT; Kolset SO; Nordstrand LM; Prydz K
J Biol Chem; 2002 Sep; 277(39):36272-9. PubMed ID: 12138122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
